CPH 0.00% 0.9¢ creso pharma limited

Ann: Quarterly Update & Appendix 4C, page-60

  1. 683 Posts.
    lightbulb Created with Sketch. 130
    Hence the company in this case would be silly if they were not garnering this opportunity. Hope that helps.


    Well.. thats my point.. why are they not spending on R&D? we are a month away from Financial Year End and these guys spent $37,000 on research for the year?

    If you have Netflix... go watch Dirty Money with the episode on Valeant Pharmaceuticals.... NOT SAYING its the same here... but it gives you an idea how manipulative things can get in the market... Its all about "making deals"...




 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.